Skip to content

Ponatinib Hydrochloride

Brand name: Iclusig

Ponatinib Hydrochloride comes in 5 pill versions in our database, in 4 strengths, from 2 manufacturers. Check the imprint to tell them apart.

Ponatinib Hydrochloride pill images

10 mg 1 pill

15 mg 2 pills

30 mg 1 pill

45 mg 1 pill

What is Ponatinib Hydrochloride used for?

Ponatinib Hydrochloride is used for myeloid leukemia.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

ICLUSIG® is indicated for the treatment of adult patients with:

Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

  • Newly diagnosed Ph+ ALL in combination with chemotherapy. This indication is approved under accelerated approval based on minimal residual disease (MRD)-negative complete remission (CR) at the end of induction. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s).
  • As monotherapy in Ph+ ALL for whom no other kinase inhibitors are indicated or T315I-positive Ph+ ALL.

Chronic Myeloid Leukemia (CML)

  • Chronic phase (CP) CML with resistance or intolerance to at least two prior kinase inhibitors.
  • Accelerated phase (AP) or blast phase (BP) CML for whom no other kinase inhibitors are indicated.
  • T315I-positive CML (chronic phase, accelerated phase, or blast phase).

Limitations of Use: ICLUSIG is not indicated and is not recommended for the treatment of patients with newly diagnosed CP-CML.

From the FDA-approved label on DailyMed (published Aug 19, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.